Apyx Medical Corp
Apyx Medical Corporation (Nasdaq: APYX) develops and sells medical devices for surgical aesthetics and provides design, development and manufacturing services to medical-device companies. Its Helium Plasma Technology is marketed as Renuvion for cosmetic surgery and J-Plasma for hospital surgery; the systems use… From the company’s description.
Over the twelve months to Sep 30, 2026, Apyx Medical Corp reported revenue of $59.57M, up 24.4% from a year earlier, and a net loss of $8.26M. Its operating margin was −5.5%, and operations used $8.23M in cash. In fiscal 2025, it reported revenue of $52.84M, up 9.9% from fiscal 2024, and a net loss of $11.11M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Apyx Medical Corp does
In the company’s own words
Apyx Medical Corporation (Nasdaq: APYX) develops and sells medical devices for surgical aesthetics and provides design, development and manufacturing services to medical-device companies. Its Helium Plasma Technology is marketed as Renuvion for cosmetic surgery and J-Plasma for hospital surgery; the systems use radiofrequency energy and helium plasma to cut, coagulate and ablate soft tissue and deliver controlled heat to tissue. The company also sells the AYON Body Contouring System, which combines fat removal, tissue contraction and electrosurgical capabilities, and offers generators and accessories through original equipment manufacturer (OEM) agreements. U.S. customers include physicians, cosmetic surgery offices and surgical centers, while international sales are primarily through distributors. Apyx reports two segments: Surgical Aesthetics, which generated 85.8% of 2025 revenue, and OEM, which generated 14.2%. The company had 205 full-time employees worldwide at December 31, 2025. Its website is www.apyxmedical.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- CLEARWATER, FL
- Fiscal year end
- December
- CIK
- 719135
- SIC
- 3841
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Apyx Medical Corp — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Apyx Medical Corp’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Apyx Medical Corp and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Apyx Medical Corp's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Apyx Medical Corp's last four quarterly filings that the numbers alone won't show?”